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The Mid-Atlantic Ethics Committee 
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Maryland Health Care Ethics 
Committee Network, an initiative of 
the University of Maryland School of 
Law’s Law & Health Care Program. 
The Newsletter combines educational 
articles with timely information 
about bioethics activities. Each issue 
includes a feature article, a Calendar 
of upcoming events, and a case 
presentation and commentary by local 
experts in bioethics, law, medicine, 
nursing, or related disciplines. 
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As Director of Ethics for Shore Health System, I have the privilege – and the challenge – of 
leading an active Patient Care Advisory 
Committee comprised of talented and 
busy professionals who are called upon 
to consult on ethics issues that arise in 
the delivery of health care for a regional 
medical system that covers a four-county 
area. The members of the committee 
include eight physicians, eight nurses, 
a social worker, two case managers, a 
chaplain, and two community members 
along with the medical librarian, a mem-
ber of the administration, as well as me 
as the Director of Ethics for the health-
care system.
Committee members are involved in 
two areas of the committee’s mission: 
writing policy and promoting ethics edu-
cation system-wide. The members also 
lend their expertise when requests for 
consultation on general topics are submit-
ted to our monthly committee meetings. 
We have addressed issues such as elective 
Caesarian-sections, mandatory flu vac-
cinations and requests for non-traditional 
practices, just to name a few. 
The Patient Care Advisory Committee 
members are less available to participate 
in clinical bedside consultations. Even 
with an on-call procedure in place, I am 
often unable to round up members of the 
committee for an in-person meeting when 
the committee’s assistance is required for 
INVOLVING GREATER PARTICIPATION OF 
AN ETHICS COMMITTEE: THE ONLINE 
CONSULTATION FORUM
urgent consultations on patient cases. 
On average, the Shore Health Sys-
tem Patient Care Advisory Committee 
responds to 140 requests a year. I am the 
only member of the committee for whom 
ethics consultation is a full-time job. All 
of the other committee members have 
volunteered to participate on the com-
mittee and each of them has other duties, 
especially the clinical members. They 
often find that they are unable to leave 
their full-time jobs to consult on an issue 
referred to the committee, especially 
when being involved may require travel-
ing 20 to 30 miles to get to one of our 
facilities. 
The Patient Care Advisory Committee 
does participate in retrospective review 
of case consultations that have been pro-
vided. This approach has several draw-
backs. Retrospective reviews do not have 
the vitality of real time discussions that 
occur as a case itself unfolds. I also find 
that reviewing a case after the fact is less 
effective as a teaching tool than learning 
by doing. Mentoring and learning must 
be connected to practice. 
I yearned for a way to capture real time 
involvement of as many of our commit-
tee members as I could in our busy and 
complex organization, which includes 
two acute care hospitals, a freestanding 
emergency center, an acute rehabilitation 
unit and several outpatient units.
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attorney.
age and broaden the members’ partici-
pation in case consultations.
I sent the reference to this article to 
the Shore Health System office of Cor-
porate Communications, whose staff 
manages the Intranet. I asked our web 
experts to read the article and let me 
know if they could develop a platform 
on which we might create our own 
consultation forum. They told me that 
this could be done. I then shared the 
article with our Patient Care Advisory 
Committee and we discussed it at the 
next meeting. The committee respond-
ed with enthusiasm and encouraged 
me to make it happen.  
I had a number of discussions with 
my Corporate Communications col-
leagues and the Internet design team 
of a local company that supports Shore 
Health System’s websites and Intranet. 
The Maryland Healthcare Ethics Committee Network (MHECN) is 
a membership organization, established by the Law and Health Care 
Program at the University of Maryland Francis King Carey School of Law. 
The purpose of MHECN is to facilitate and enhance ethical reflection in 
all aspects of decision making in health care settings by supporting and 
providing informational and educational resources to ethics committees 
serving health care institutions in the state of Maryland. The Network 
attempts to achieve this goal by:
   • Serving as a resource to ethics committees as they investigate  
 ethical dilemmas within their institution and as they strive to assist  
 their institution act consistently with its mission statement;
   • Fostering communication and information sharing among Network  
      members;
   • Providing educational programs for ethics committee members, other 
      healthcare providers, and members of the general public on ethical  
 issues in health care; and
   • Conducting research to improve the functioning of ethics committees 
 and ultimately the care of patients in Maryland.
MHECN appreciates the support of its individual and institutional mem-
bers. MHECN also welcomes support from affiliate members who provide 
additional financial support. Current affiliate members include the Johns 
Hopkins Berman Institute of Bioethics.
By luck - or perhaps providence - I 
chanced upon an article by David 
Ramsey, Mary Lou Schmidt, and Lisa 
Anderson-Shaw (2010) in the Jounrnal 
of Nursing Administration’s (JONA’s) 
Healthcare Law, Ethics, and Regula-
tion, “Online ethics discussion forum 
facilitates medical center clinical case 
reviews.” The authors described their 
development and use of a web-based 
discussion board with secure access 
by their ethics committee members. 
The Intranet-based forum was used to 
facilitate real time discussion of open 
and active ethics consultations within 
the University of Illinois at Chicago 
Medical Center. They described how 
the forum is encrypted and secure and 
how it has been in operation for ten 
years. I immediately thought that this 
forum was exactly what the Shore 
Health System Patient Care Advisory 
Committee was looking for to encour-
Online Consultation Forum 
Cont. from page 1
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In just a couple of months, they de-
signed a forum for me to review. 
I enlisted the help of two other 
members of our Patient Care Advisory 
Committee. We went through a testing 
and refining period that resulted in a 
product presented to the committee, 
which includes our Corporate Compli-
ance Officer. The group approved the 
forum and we are now using it for our 
ethics consultation system-wide. 
The forum works easily. I identified 
the people who have approved ac-
cess to the system. They each have a 
password that they use to log on to the 
home page of the forum. For security 
reasons, users must enter their user 
name and password each time they en-
ter the forum; they cannot sign in once 
and stay logged in indefinitely. 
Once a user enters the home page, a 
number of actual forums appear. It is 
possible to have any number of active 
forums on the opening page. Currently 
we have four forums: 
• open cases for the calendar year
• closed cases for the calendar 
year 
• a journal club 
• a policy forum for posting 
and discussing administrative 
policies directly involving the 
Patient Care Advisory Commit-
tee, such as DNAR, MOLST 
and organ transplantation 
The Open Case forum contains all 
cases that are active and in process. 
The cases are identified by date and 
time of request, location of the patient, 
and a brief description of the nature 
of the request (e.g., end of life, code 
status, surrogate conflict). 
When the case portal is opened, the 
first thing that the committee mem-
ber sees is a fairly detailed descrip-
tion of the case. A template is used, 
which includes the date and time of 
the request; basic patient identifying 
information; location; urgency as de-
fined by the requestor and consultant; 
persons involved in the care of the 
patient; how the requestor conceives 
of the issues at hand; the presence of 
an advance directive and a summary 
of its contents; code status; family 
involvement; background and medical 
history; the ethics issues as perceived 
by the consultant; involvement of the 
patient or surrogates; actions taken; 
follow-up and outcomes; date of clos-
ing the case; time spent on the case, 
including documentation; reflections 
for improvement; and the consultant’s 
identification. 
When a new case is posted in the 
forum, members of the committee 
receive an email alerting them that a 
new case is open and awaiting feed-
back. Once notified, the committee 
members may read the information 
on the template and then post com-
ments, questions and suggestions in 
a string that appears just below the 
opening case information. Each com-
ment that is made in response to the 
case is posted with a time stamp and 
generates an email that is sent to the 
committee members, informing them 
that comments have been posted to 
the currently active case at hand. This 
feature encourages more involvement 
and, since it is our experience that a 
majority of cases remain open for at 
least a day and on average three days, 
comments can be posted at any time. 
The consultant can also be involved in 
the conversation, answering questions, 
clarifying points of information and 
adding to the original case study as 
events may dictate. 
When the case is resolved and 
closed, a note is posted by me as the 
forum administrator in the forum 
informing the committee of the case’s 
outcome and closing. The case is then 
moved to the closed case forum for the 
calendar year. 
Shore Health System uses an elec-
tronic medical record system and the 
consultant dictates a summary of the 
consultation in the patient’s medical 
record. The forum description and 
conversation is not placed in the medi-
cal record and remains as a resource 
for the committee. All consultations 
are generated electronically as well 
and are sent to my office as the Direc-
tor of Ethics for the system. 
The ethics forum does not replace 
in-person consultation and live dis-
cussions. However, having this tool 
expands the participation of committee 
members who may be unable to attend 
a meeting as the case unfolds.
Another very important feature 
of the forum that we modeled after 
the University of Illinois at Chicago 
Medical Center is the ability to search 
the forum for information that might 
be important to the committee. We 
can see trends in the types of cases 
for which consultations are needed by 
grouping the cases by medical issue, 
urgency, patient area within the sys-
tem, and by the identity and role of the 
requestor. Because our policy allows 
anyone to call for an ethics consulta-
tion - nurses, doctors, case managers, 
patients and their family members - 
we anticipate that this search function 
will be very useful as we use this tool 
over time.
I already see many benefits of hav-
ing this ethics forum in place. The 
forum has made it possible for us to 
streamline committee meetings since 
every member has access to the case 
material, which makes it possible to 
move through the retrospective review 
of cases in a more economical fashion. 
The forum also
• facilitates learning 
Cont. on page 4
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BioethX LAUNCHING NEW CONSULT MANAGEMENT SERVICE
BioethXTM, a Maryland-based company, is launching the first commercial Web-based 
system to assist healthcare ethics 
consultants in their management of 
ethics consultations. All that is needed 
is a computer with a standard web 
browser and an Internet connection. 
The system maintains a roster of all 
individuals who are authorized and 
eligible to become involved in ethics 
consultations. Shared access among 
designated consultants to a common 
repository of information streamlines 
communications and allows the inclu-
sion of consultants, no matter where 
they are. The system supports noti-
fications via email to ensure timely re-
sponse and coordination of activities 
by advising consultants of referrals, 
reminders and planned activities. 
A key feature of the system is its 
ability to help manage ethics con-
sultations by cueing users to follow 
an established workflow process for 
orderly execution of activities that 
typically lead to well-managed ethics 
consults. This guidance can be par-
ticularly useful for less experienced 
consultants, but for more experienced 
consultants or in fast-paced environ-
ments, a streamlined process supports 
efficient provision of concise consult 
information. 
Automation of the documentation 
process is an advantage over paper-
based methods employed by most 
organizations today. It supports ef-
ficient capture and centralized storage 
of key information and online sharing 
of that information among involved 
consultants. This can greatly improve 
the individual productivity of eth-
ics consultants. Simultaneous online 
access to shared resources improves 
collaboration among staff members, 
greatly reducing coordination and 
communications overhead activities 
and enabling the inclusion of ad-
ditional participants in a consult for 
added expertise and peer validation. 
Comprehensive reports can be easily 
generated on consulting activities 
across an entire facility.  
This system provides a secure 
portal for information-sharing among 
ethics consultants, generates an eth-
ics consultation summary to put in 
a patient’s health record (for case 
consultations), or to provide to those 
who requested a consult, and allows 
for tracking consultation performance 
and outcomes. All network trans-
missions are protected by the same 
HTTP/SSL encryption widely used 
and accepted today for other health-
care applications, e-commerce, and 
online banking systems. The service 
is fully HIPAA-compliant.
For more information, visit www.
bioethx.net, or contact Ben Martin-
dale at bmartindale@bioethx.net.
COMPLIANCE TOOLBOX WIKI NOW AVAILABLE
Are you interested in Healthcare Compliance and Ethics? Then you will want to visit the Compliance Toolbox 
wiki at http://compliance-toolbox.wikispaces.com. Martha Ann Knutson, JD, CHC, developed this wiki after dis-
covering the absence of organized online content on this subject.  She also realized that many individuals doing 
compliance and ethics in healthcare settings remain isolated in single or slimly staffed departments where they 
may not have someone to ask “what do you think?” or “have you seen …”? So, there is a discussion section in the 
Toolbox where you can post a question if the wiki doesn’t have an answer to your question. There is also a function 
for getting notifications when something is added to the site or to a particular page so that you don’t have to spend 
time checking back.  This is a non-commercial venture that Ms. Knutson (a former MHECN education committee 
member) has developed as her own initiative. Membership is free. Whether you become a member of the wiki or 
not, send any feedback on the concept or any ideas you might have to improve it to maknutson@gmail.com.
Online Consultation Forum 
Cont. from page 3
• encourages greater collabo-
ration in case consultations 
among all members of the com-
mittee
• allows us to share information 
published in the literature via 
attachments
• provides a discussion board 
for members to participate in a 
journal club 
• gives us access to informa-
tion that will be of value for an 
analysis of our work in general
Brian H. Childs, Ph.D.
Director of Ethics
Shore Health System
University of Maryland Medical 
System
Easton, Maryland
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MEDICALLY INEFFECTIVE TREATMENT 
 UNDER MARYLAND LAW:
UPDATE ON MHECN’S EFFORTS TO ADDRESS CONCERNS
Maryland’s Health Care Decisions Act (HCDA) allows two physicians to 
certify that a treatment is “medi-
cally ineffective” (sometimes called 
“futile”) if it will not “prevent or 
reduce the deterioration of the health 
of an individual,” or prevent “the 
impending death of an individual,” 
to a reasonable degree of medical 
certainty. Such treatment may then be 
withheld or withdrawn after certain 
procedural steps are followed. In 
2009, MHECN surveyed Maryland 
adult intensive care unit (ICU) physi-
cians, risk managers, and hospital 
attorneys to identify their awareness, 
understanding, and interpretation of 
Maryland’s HCDA. On November 
30, 2010, MHECN held a symposium 
to address concerns about differing 
interpretations of the law that present 
a barrier to withholding or withdraw-
ing medical treatments considered 
medically ineffective. Last Septem-
ber, MHECN sponsored a round table 
discussion with Maryland hospital at-
torneys and risk managers to consider 
possible solutions to ensure more 
uniformity in implementing the law 
as regards withholding and withdraw-
ing medically ineffective treatment.
ETHICAL JUSTIFICATION  
FOR MEDICAL FUTILITY  
LEGISLATION
Empowering clinicians to with-
hold or withdraw medical treatment 
deemed ineffective may be justified 
based on concerns that the treatment 
may harm the patient (i.e., a “best 
interest” ethical standard), that the 
treatment may not be what a patient 
who previously had decision-making 
ability would now want (i.e., a “sub-
stituted judgment” ethical standard), 
or that providing the treatment may 
constitute poor stewardship of limited 
health care resources (i.e., a “justice” 
ethical standard).  Laws regulating 
medical futility decisions are directed 
toward supporting good medical prac-
tice that is fair and consistent across 
institutions.
ARGUMENTS IN FAVOR  
OF MEDICAL FUTILITY  
LEGISLATION
Proponents of medical futility laws 
and policies argue that surrogate 
decision-makers are unnecessarily 
burdened by “false choices” to stop 
treatments that are only prolong-
ing their loved one’s death and not 
providing a benefit. They consider 
requests to “do everything” for a dy-
ing loved one as an expected reaction 
of grief that should be met with ap-
propriate palliative interventions, and 
that succumbing to aggressive end-of-
life interventions to appease bereaved 
family members at times amounts to 
“expensive grief therapy.” Moreover, 
health care staff experience moral dis-
tress when they provide life support 
interventions that they perceive cause 
more burden than benefit to dying pa-
tients, and that diminish the dignity of 
the dying process. Lastly, using ICU 
technology on patients who cannot 
benefit from it deprives others who 
may benefit, and demonstrates poor 
resource allocation. 
ARGUMENTS OPPOSED  
TO MEDICAL FUTILITY  
LEGISLATION
Opponents of such laws argue that 
less adversarial and more humane 
and compassionate approaches are 
available to help dying patients and 
family members than futility legis-
lation. With good communication, 
these requests to continue medically 
ineffective/non-beneficial treatment 
are rare; as such, a hard line approach 
is unwarranted. Futility stand-offs 
may be the result of clinicians’ poor 
palliative care and end-of-life com-
munication skills, and futility laws 
do not provide incentives to physi-
cians to avoid such stand-offs. Also, 
clinicians should take responsibility 
for determining and implementing the 
medical standard of care and not rely 
on legislation that provides them with 
legal immunity. 
HCDA MAIN CONCERNS 
The main concerns expressed about 
the HCDA relates to the following 
provision:
“A health care provider that 
intends not to comply with an in-
struction of a health care agent or a 
surrogate shall:
(1) Inform the person giving the 
instruction that:
 (i) The health care provider 
declines to carry out the instruction;
 (ii) The person may request 
a transfer to another health care 
provider; and
 (iii) The health care provider 
will make every reasonable effort to 
transfer the patient to another health 
care provider;
(2) Assist in the transfer; and 
(3) Pending the transfer, comply 
with an instruction of a competent 
individual, or of a health care agent 
or surrogate for an individual who 
is incapable of making an informed 
decision, if a failure to comply with 
the instruction would likely result 
in the death of the individual.”
First: Legal counsel and risk man-
agers at some institutions feel it is 
unclear whether a guardian needs to 
be appointed to withhold or withdraw 
medically ineffective treatment for a 
patient who has no identifiable sur-
rogate.
Second: Many are concerned that 
Cont. on page 9
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CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an 
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit 
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the 
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify 
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to  
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey 
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
CASE STUDY FROM  
A NURSING HOME
Mr. Smith, a retired truck driver, was a seventy-three-year-old widower and 
former World War II prisoner of war. 
He had been living in a nursing home 
for two weeks. Upon admission, it 
was noted that he had several enlarged 
lymph nodes in his neck. A history 
was taken, and the nursing home phy-
sician found that approximately four 
years ago Mr. Smith had been treated 
for laryngeal cancer with radiation 
therapy. The physician immediately 
requested an oncology consult. The 
oncologist made the decision that Mr. 
Smith could remain in the nursing 
home for the workup. A CAT (com-
puterized axial tomography) scan 
revealed a mass in and around the left 
vocal cord, and a biopsy confirmed the 
recurrence of the cancer. The oncolo-
gist presented Mr. Smith with a choice 
of surgery or chemotherapy. Before 
Mr. Smith could make a decision, a 
woman named Mrs. Adams presented 
herself. She announced that she was a 
long-time friend of the resident's fam-
ily and that she was, in fact, the resi-
dent's health care proxy, according to 
a signed durable power of attorney for 
health care, with full decision making 
powers regarding all of the resident's 
medical treatment. This news raised 
the question of the resident's capac-
ity in the progress notes for the first 
time. A psychiatric consult revealed 
that the resident had the capacity to 
make health care decisions. However, 
the durable power of attorney docu-
ment indicated that it went into effect 
immediately—not upon the resident's 
incapacity.
The oncologist was not sure how to 
proceed. He stated that initially Mr. 
Smith seemed to prefer the chemo-
therapy, but when Mrs. Adams refused 
to consent to chemotherapy he seemed 
"noncommittal" about his treatment in 
the sense that he "agreed to anything." 
The oncologist indicated that "without 
the consent of the medical power of at-
torney," he would not feel comfortable 
giving chemotherapy, even though it 
was indicated.
Mrs. Adams called the facility's 
social worker out of concern about the 
home's efforts to obtain Mr. Smith's 
consent for the chemotherapy. She 
stated that she knew the resident did 
not want chemotherapy, since he had 
told her after his earlier radiation 
therapy that he did not want "any more 
treatments." She said that the resident 
was illiterate and had no experience 
in making important decisions for 
himself. Before her death, his wife had 
made all financial and other decisions 
for the couple. The wife had made it 
clear that Mrs. Adams should assume 
and continue these same functions for 
Mr. Smith. Mrs. Adams also revealed 
that she worked for a private oncolo-
gist and knew all about chemotherapy 
and that she could not in good con-
science consent to such treatment for 
Mr. Smith. She would, however, be 
willing to consent to the surgery.
How should the nursing home 
handle this case?
NOTE: Below, the commentators on 
this case use different terms to de-
scribe the role of Mrs. Adams—agent, 
proxy, and surrogate. Some state 
statutes use very specific language to 
describe a legally appointed agent—
for example, New York calls them 
“health care agents” and Florida calls 
them “surrogates.” New York state 
calls the document by which an agent 
is appointed the health care proxy. 
New York state defines a "surrogate” 
as a person not legally appointed by 
the resident to make health care deci-
sions. Even when similar terms are 
used or two different terms seem to be 
functional equivalents, it is imperative 
that an ethics committee understand 
what power a state's law gives to the 
term. For example, a "surrogate” in 
one state may be able to make any and 
all decisions, whereas in another state 
a law might limit the kinds of decisions 
a surrogate can make—for example, 
only decisions that will not end in the 
death of the person on whose behalf he 
or she speaks.
COMMENTS FROM A HEALTH 
   LAW PROFESSOR
The significant question in this case 
is whether Mr. Smith has the capacity 
to make his own health care decisions. 
If so, he has the right to make his own 
treatment decisions in spite of having 
a duly appointed health care agent. 
There is nothing in the case which in-
The following case study and  
responses are reprinted with permis-
sion from the Handbook for Nursing 
Home Ethics Committees, edited by 
Diane Hoffmann, Philip Boyle, and 
Steve Levenson, and published by the 
American Association of Homes and 
Service for the Aging in 1995.
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dicates that he lacks decision-making 
capacity. Surely, the inability to read 
is not a prerequisite for the ability to 
make medical decisions. Yet, this case 
presents a troubling and confusing 
scenario for many health care provid-
ers. The confusion comes from having 
a legal document—a durable power of 
attorney for health care—that clearly 
states that the named agent (Mrs. Ad-
ams) has the authority to make health 
care decisions for the principal (Mr. 
Smith).
Legally, a person may execute a du-
rable power of attorney for health care 
that takes effect prior to the principal's 
incapacity. In Maryland, for example, 
the model statutory form provides the 
principal with the option of having the 
agency take effect upon the principal's 
incapacity or when the principal signs 
the document. Some individuals—in 
particular, those who are elderly and 
infirm—want their spouse or child to 
make health care decisions for them, 
even though they have the capacity to 
make health care decisions. They trust 
these individuals to make the right 
decision for them. They may be too 
sick or too weak to concentrate on the 
issues, perhaps due to certain sedating 
drugs or because they are uncomfort-
able or in pain.
The appointment often works 
smoothly. However, health care 
providers are appropriately troubled 
when the agent instructs them to do 
something that is inconsistent with the 
expressed wishes of the principal. As a 
legal matter in those cases, the wishes 
of the principal take precedent. This 
is so for two reasons. First, a principal 
can always revoke the appointment of 
the agent. Every state's durable power 
of attorney for health care statute has 
a provision for revocation. In many 
cases, the revocation can be accom-
plished simply by an oral statement 
from the principal. Other jurisdictions 
require destruction of the original 
document or execution of another 
document. While this alone is suffi-
cient reason for health care providers 
to listen to the principal rather than his 
agent, there is also a second reason. 
Most state statutes governing health 
care agents provide that these agents 
must make a decision that is consistent 
with the resident's known wishes. The 
agent is not to make a decision that is 
at odds with the resident's expressed 
wishes.
In this particular case, there is a third 
reason to be skeptical of Mrs. Adams's 
role. It is not totally clear whether the 
original durable power of attorney is 
valid, for it is questionable whether 
Mr. Smith actually understood what he 
was signing and whether he agreed to 
it. Mrs. Adams states at one point that 
Mr. Smith's wife had made it clear be-
fore her death that Mrs. Adams should 
continue to make the same type of 
important decisions for Mr. Smith as 
Mrs. Smith had. There is no indication 
that these were Mr. Smith's wishes, 
and the fact that he cannot read raises 
questions about his full understanding 
of the document he signed.
While this case is rather straightfor-
ward as a matter of law, as a practical 
matter it is still problematic. Mr. Smith 
appears somewhat intimidated by Mrs. 
Adams and seems to defer to her. As a 
result, even if the agency is revoked, 
Mr. Smith may still be influenced by 
Mrs. Adams. Some effort needs to be 
made to speak with Mr. Smith alone 
and explain to him his right to make 
his own health care decisions. This 
alone may not be sufficient to get 
him to make an independent deci-
sion, especially if he feels in any way 
dependent on Mrs. Adams for further 
care. Therefore, someone from the 
facility also needs to talk to Mrs. 
Adams and explain to her the limits 
of her authority and the rights of Mr. 
Smith to make his own decisions. She 
may feel as though she is protecting 
Mr. Smith from the "medical establish-
ment," given her experience working 
for an oncologist, and she may feel 
that the oncologist in this case is not 
being fully honest with Mr. Smith. As 
a result, it might be helpful if someone 
who is not from the medical staff, such 
as the facility administrator or clergy, 
speaks to Mrs. Adams.
The personal dynamics in this case 
appear more troublesome than the 
actual legal or ethical problem. We are 
not privy to the historical or current re-
lationship between Mr. Smith and Mrs. 
Adams. This information is essential 
to understanding how Mr. Smith 
views his choices in this case. A social 
worker or someone trained in counsel-
ing skills may be helpful in getting 
Mr. Smith to describe his relationship 
with Mrs. Adams and why he appears 
intimidated by her. If such information 
can be obtained, steps might be taken 
to alleviate Mr. Smith's concerns. If 
not, the nursing home must continue 
to confer with Mr. Smith and follow 
his instructions—even allowing him to 
defer to Mrs. Adams if he fully under-
stands the implications of that choice.
Diane E. Hoffmann, JD, MS
Director, Law & Health Care Program 
& Professor of Law
University of Maryland 
Francis King Carey School of Law 
COMMENTS FROM A  
  RELIGIOUS STUDIES  
  PROFESSOR
This case underscores the impor-
tance of identifying surrogates or 
proxies and involving them in care 
planning as soon as possible. The sud-
den appearance of Mrs. Adams turns 
Mr. Smith passive, halts his planned 
chemotherapy treatment, and presents 
the nursing home with some question-
able explanations to sift through. Mrs. 
Adams's rationale for refusing che-
motherapy is not only inconsistent in 
itself, but at variance with Mr. Smith's 
own preference. In short, Mr. Smith's 
personal values and his best interests 
may well be jeopardized by Mrs. 
Adams's decision making. The nurs-
ing home is dealing with a potentially 
undependable proxy.
Mrs. Adams's primary obligation is 
to make treatment decisions reflect-
ing Mr. Smith's own preferences. In 
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the absence of stated preferences, her 
decisions should be guided by Mr. 
Smith's basic values and beliefs. More-
over, Mr. Smith still has decision-
making capacity. (Despite what Mrs. 
Adams implies, his illiteracy does not 
constitute decisional incapacity.) Mrs. 
Adams can elicit Mr. Smith's actual 
preferences for treatment. There is, 
however, no indication that she does 
so. She has played no active role in 
Mr. Smith's admission to the nursing 
home or in the subsequent decisions to 
proceed with a diagnostic work-up and 
biopsy. Her lack of contact with Mr. 
Adams is made more troubling by the 
revelation that she was named proxy 
not by Mr. Smith himself, but by his 
now deceased wife. On the whole, 
Mrs. Adams does not seem to have 
the kind of ongoing contact with Mr. 
Smith that would make her a well-
informed proxy.
Moreover, her explanation for 
refusing chemotherapy is disturbingly 
inconsistent. She bases the refusal 
on Mr. Smith's statement, four years 
earlier, that he did not want "any more 
treatments." Yet she indicates that she 
would consent to surgery—certainly a 
"treatment," perhaps even more drastic 
than chemotherapy. She further clouds 
her refusal by saying she has worked 
for an oncologist and knows "all 
about" chemotherapy. Her announced 
certitude here suggests that she will 
not seek medical advice for Mr. Smith, 
much less weigh it seriously. In sum, 
her failure to elicit Mr. Smith's present 
wishes, her dismissal of his decision-
making ability, and her absolutist stand 
about oncology all suggest a poorly 
informed, potentially coercive proxy.
On the other hand, proxies need not 
be "perfectly" rational, expertly in-
formed, medically "obedient" decision 
makers, any more than the residents 
they represent. Biased, information-
resistant, potentially coercive proxies 
can function validly—up to a point. 
Determining that point is, of course, 
a critical task for care providers. The 
rights and powers of proxies are not 
absolute. The obligations of care 
providers to respect residents' prefer-
ences and to pursue their best interests 
should not be abrogated by a dubious 
proxy. And Mrs. Adams is perilously 
close to being dubious.
The oncologist's reactions too are 
morally questionable. His temporiz-
ing suggests legalistic paralysis more 
than moral caution. If the oncologist 
is inhibited by Mrs. Adams's refusal 
of consent, the nursing home should 
not be. The home should engage Mr. 
Smith in further conversation to clarify 
the reasons behind his initial choice of 
chemotherapy and his later vagueness 
when Mrs. Adams vetoes the treat-
ment. The nursing home should also 
make sure that Mr. Smith recognizes 
his rights to determine his own care 
and to reject or accept Mrs. Adams's 
surrogacy. Certainly, the home's ad-
ministrators should ask how he wants 
them to proceed when Mrs. Adams 
makes decisions that run counter to his 
own preferences.
Full and open communication with 
Mrs. Adams would also be essential. It 
would provide the nursing home with 
an opportunity to voice its concern 
that she has overridden Mr. Smith's 
stated preference and that her explana-
tions for this are troubling. Discussion 
of this sort might stir some second 
thoughts in Mrs. Adams and might 
give the nursing home a better un-
derstanding of her style of surrogacy. 
If no deeper mutual understanding 
results, the home should be ready to 
take whatever formal action might be 
necessary to challenge Mrs. Adams's 
decision in this particular instance and 
perhaps to challenge the appropriate-
ness of her being a proxy altogether.
In dealing with this case, the nursing 
home's staff will be helped immensely 
if the facility has clear policies and 
procedures for dealing with conflicts 
that arise around surrogate/proxy 
decision making. The home's ethics 
committee should have a clear role 
in making and reviewing such policy 
and in carrying out the education that 
would make it effective. In particular, 
an ethics committee looking at this 
case retrospectively might want to ex-
amine its facility's admissions process, 
especially in light of the Patient Self-
Determination Act (PSDA).
A minimalist response to the PSDA 
requires only the formality of a ques-
tion about the existence of an advance 
directive. A full-fledged response, 
however, would call for an in-depth 
exchange about the content of the 
directive and the identity of any surro-
gates named (Johnson, 1991). Such an 
exchange might have uncovered Mrs. 
Adams's proxy status (and its potential 
problems) at a much earlier point. The 
committee might also feel the need for 
educational work with staff mem-
bers on questions relating to advance 
directives. Mr. Smith has executed an 
"immediate" durable power of attorney 
and not the more common "spring-
ing" durable power of attorney (which 
would go into effect only in the event 
of his decisional incapacity) (New 
York State Task Force, 1987). It would 
be especially crucial for nursing home 
staff to know about this type of agency 
since it is active even when a resident 
has decision-making capacity. For that 
reason it can seriously complicate the 
decision-making process—as this case 
amply indicates.
Bart Collopy, PhD
REFERENCES
Johnson, S. (1991). “PSDA in the 
Nursing Home,” in “Practicing the 
PSDA,” special supplement, Hast-
ings Center Report, 21(5), 53-S4.
New York State Task Force on Life 
and the Law (1987), Life-Sustaining 
Treatment: Making Decisions and 
Appointing a Health Care Agent, pp. 
95-100; see p. 41.
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there is no limit to how long treat-
ments need to be continued pend-
ing transfer, since in most situations 
where clinicians decide that particular 
interventions are medically ineffective, 
there is no transfer option.
PROPOSED SOLUTION
Jack Schwartz, JD, Adjunct Pro-
fessor at the University of Mary-
land Francis King Carey School of 
Law and former Maryland Assistant 
Attorney General, has proposed a 
solution through rule-making through 
the Department of Health and Men-
tal Hygiene (DHMH). Assuming 
that DHMH might be open to this 
approach, which is speculative at 
present, this option would involve 
elevating certain Attorney General 
opinion letters to regulatory status. For 
example, one opinion letter states that 
if there is no identifiable surrogate to 
notify regarding a decision to with-
hold or withdraw medically ineffective 
treatment (after reasonable efforts to 
locate a surrogate have been made), 
it is not necessary to appoint a guard-
ian simply to have someone to notify. 
In addition, such regulations might 
clarify how long to maintain interven-
tions deemed medically ineffective 
pending transfer. At the attorney/risk 
manager round table last September, 
most attendees supported this ap-
proach. Thus, efforts are underway to 
draft this regulatory language.
ONE PART OF A BIGGER  
PICTURE
Medical futility laws are most often 
invoked for individuals whose death is 
impending, where a question is raised 
about the ability of aggressive life-
prolonging interventions to achieve a 
benefit for the patient. What is clear is 
that such individuals deserve excellent 
palliative care, which includes com-
fort care and psychospiritual support 
(the latter for both the patient and his 
or her loved ones). All clinicians are 
obligated to ensure that patients have 
access to excellent palliative and end-
of-life care, regardless of whether the 
patient’s dying process is prolonged 
through medical technology. Taking 
“false decisions” off the shoulders 
of surrogate decision-makers is good 
medical practice. Maryland’s HCDA is 
intended to support that process, but it 
cannot replace good medical practice. 
Toward that end, more education is 
needed for health care professionals, 
legal guardians, attorneys, risk manag-
ers, and the public to ensure that state 
legislation and regulation supports 
best medical practice. 
If you have questions about these 
efforts, contact MHECN Program Co-
ordinator Anita Tarzian at atarzian@
law.umaryland.edu.
Medically Ineffective Treatment 
Cont. from page 5
MHECN PROGRAM COORDINATOR ANITA TARZIAN RECEIVES AWARD
On October 15, 2011, MHECN’s Program Coordinator Anita J. Tarzian, PhD, RN was awarded The Distinguished 
Service Award from the American Society for Bioethics and Humanities (ASBH). Dr. Tarzian’s service to ASBH 
over the years has included serving as a Board Member at Large (2002-2004), as 
Board Secretary (2004-2008), and currently, as Chair of the Clinical Ethics Consul-
tation Affairs (CECA) Standing Committee. CECA recently published a report with 
recommendations to the ASBH Board regarding whether and how to certify ethics 
consultants and accredit programs that train them. It also advises the Board on is-
sues related to health care ethics and standards for ethics consultation. In addition, 
ASBH recognized Dr. Tarzian’s service as Chair of the Core Competencies Update 
Task Force, which produced the second edition of the report, Core Competencies for 
Health Care Ethics Consultation (published by ASBH in 2011).
As Program Coordinator of MHECN, an initiative of the University of Maryland 
School of Law, Dr. Tarzian serves as a resource for health care ethics committee 
members in Maryland and the mid-Atlantic region. A former surgical oncology nurse 
and hospice nurse, she is currently Associate Professor at the University of Maryland 
School of Nursing in the Department of Family and Community Health. Her profes-
sional focus has been in clinical and research ethics, including clinical ethics consultation in acute and long-term 
care settings, ethics education, palliative care, hospice, the influence of culture on health care decision-making, and 
disability rights. Dr. Tarzian received a Doctorate in nursing research (ethics track) and a Masters in Intercultural 
Nursing from the University of Maryland School of Nursing, a Bachelor of Science in Nursing from Rush Univer-
sity, and a Bachelor of Arts from Knox College. 
Anita J.  
Tarzian, PhD, RN
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FEBRUARY
8 
End-of-Life Nursing Care Workshop. ELNEC-based course sponsored by the University of Maryland Medi-
cal Center’s Office of Clinical Practice and Professional Development. Paca Pratt Learning Center, Room 7A, 
UMMC, Baltimore, MD. For more information, contact kgorman@umm.edu. 
13 (1-2PM) 
Embracing Cultural Diversity in Medical Practice. Sponsored by the UMMC Ethical Advisory Committee. 
University of Maryland Medical Center, 22 S. Greene St., Baltimore, MD, Shock Trauma Auditorium. For more 
information, contact Hsilverm@medicine.umaryland.edu.
16 (6-7:30PM) 
The Ethics of Erasing Memories “Eternal Sunshine” Style. Speaker Matthew Liao, Ph.D., Center for Bioethics, 
New York University.  Columbia University Morningside Campus, New York, NY. To RSVP or for more informa-
tion, contact Meghan Sweeney at ms4184@columbia.edu. 
MARCH 
4 (6 PM) 
“Am I My Genes?” Sphinxes, Chimeras, & Other Mixes of Species in Science & Art. Speaker Robert Klitzman, 
MD, Dept. of Psychiatry, CUMC, Guggenheim Works & Process Series. Solomon R. Guggenheim Museum, 1071 
5th Ave. (at 89th St. ), New York, NY. For more information, contact ms4184@columbia.edu.
13-14 
Mixed Messages: Ethical Tensions in Healthcare Conversations. Sponsored by the Health Care Ethics Consortium 
of Georgia (HCECG) and the Emory University Center for Ethics, at the Emory University Center for Ethics, 
Atlanta, Georgia. For more information, visit www.hcecg.org, or call 404-727-9533.
15 (6-7:30 PM) 
Speaker Oliver Sacks, MD, Low 207, Columbia University Morningside Campus,  Columbia University, New 
York, NY. To RSVP or request more information, contact Meghan Sweeney at ms4184@columbia.edu. 
16 
Ethics of the Heart II: Ethics and Policy Challenges in Congenital Heart Disease. Sponsored by the Penn Car-
diovascular Institute, the Cardiac Center at the Children's Hospital of Philadelphia (CHOP) and the Center for 
Bioethics at the University of Pennsylvania. CHOP, Philadelphia, PA. For more information, contact james.
kirkpatrick@uphs.upenn.edu.
CALENDAR OF EVENTS
MARYLAND MOLST UPDATE
DHMH's rulemaking, which is needed to complete the process of getting MOLST into final legal form, is still pend-
ing. The comment period has closed, and as of this writing DHMH continues to evaluate the comments. Meanwhile, 
MOLST has already come into voluntary use across the state. Many health care facilities and programs are finding 
that MOLST is a very useful tool for carrying out already established legal and ethical obligations. In addition, 
MIEMSS accepts MOLST as the equivalent of an EMS/DNR order. Therefore, although the use of MOLST is not 
yet legally required, its voluntary use now may be valuable in framing conversations with patients and their families 
about care planning and in documenting the clinical steps needed to carry out care plans. A wealth of MOLST-
related information and training aids may be found on this DHMH website: http://dhmh.md.gov/marylandmolst/
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CALENDAR OF EVENTS (cont'd)
30-April 1 
“The Significance of Neuroscience for Morality: Lessons from a Decade of Research” (Part I), and  
“Can Moral Behavior be Improved or Enhanced?” (Part II). Sponsored by the NYU Center for Bioethics, Duke 
Kenan Institute for Ethics, Yale Interdisciplinary Center for Bioethics, and the Institute for Ethics and Emerging 
Technologies. New York University, WSQ Campus (room TBA). For more information, contact bioethicscon-
ference@nyu.edu or visit http://bioethics.as.nyu.edu/object/bioethics.events.20120330.conference
APRIL 
12-13 
New Technologies, New Challenges: Women and Prenatal Genetic Testing in the 21st Century. Jointly Spon-
sored by the Department of Bioethics at the Cleveland Clinic and the Center for Genetics Research, Ethics and 
Law at the Case Western Reserve Medical School. Case Western Reserve University School of Law, Cleveland, 
OH. For more information, visit http://www.law.case.edu/Lectures.aspx?lec_id=295, or call 216-368-1798 (toll-
free 888-814-5878). 
17 (12-1:15P) 
Advance Care Planning: Addressing the Gaps between Knowledge and Practice. Speaker: Myra J. Christopher, 
Center for Practical Bioethics. Annual Shallenberger Lecture in Ethics, sponsored by the Johns Hopkins Hospi-
tal Ethics Committee and Consultation Service. For more information, contact Sharon Mears at smears@jhmil.
edu, 410-955-0620.
26-27 
Borders and Barriers: Mapping a Moral Path. This conference will have a Hot Topics track that will focus on 
high profile issues in the healthcare headlines and an Issues in Practice track that will focus on applied topics for 
individual and ethics committee development. Sponsored by the Colorado Healthcare Ethics Forum. Stonebrook 
Manor Event Center and Gardens, Thornton, Colorado. For more information, visit http://coloradoethicsforum.
org/ 
MAY
1 - 3 
Ethics Education in a Global Perspective. Inaugural International Conference on Education in Ethics. Organized 
by the International Association for Education in Ethics (IAEE) and the Center for Healthcare Ethics. Duquesne 
University, Pittsburgh, Pennsylvania. For more information, visit http://www.duq.edu/healthcare-ethics/iaee/, or 
e-mail iaee@duq.edu. 
10-11 
Reforming Ethics and Humanities Teaching in Medical Education: Fulfilling Future Accreditation Goals on 
Professionalism. Sponsored by the Romanell Fund for Bioethics Pedagogy at the University at Buffalo and the 
University of Louisville. The Brown Hotel, Louisville, KY. For more information, visit www.primemedicine.
org.
15-16 
Hospitals, Healthcare, and the Medical Humanities. Sponsored by Children's Hospital of Pittsburgh, 4401 Penn 
Avenue, Pittsburgh, PA. For more information, contact meeting Lisa Parkera (lisap@pitt.edu) or Valerie Satko-
skeab (vbv2@pitt.edu).
31-June 1 
Third Annual Conference of the International Society of Advance Care Planning and End of Life Care. For more 
information, visit http://www.acpelsociety.com/conference/.
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